134 results match your criteria: "Dana-Faber Cancer Institute.[Affiliation]"

Background: Use of 5 mg/day finasteride (Proscar) for benign prostatic hyperplasia is known to affect serum concentrations of prostate-specific antigen (PSA). When men taking this treatment undergo screening for prostate cancer, a compensatory adjustment of the PSA concentration (to multiply the value by two) is recommended. Whether this recommendation should apply to men taking 1 mg/day finasteride (Propecia) for the treatment of androgenic alopecia is unknown.

View Article and Find Full Text PDF

Background: Substantial debate centers on the high cost and relative value of new cancer therapies. Oncologists play a pivotal role in treatment decisions, yet it is unclear whether they perceive high-cost new treatments to offer good value or how therapeutic costs factor into their treatment recommendations.

Methods: We surveyed 139 academic medical oncologists at two academic hospitals in Boston.

View Article and Find Full Text PDF

Purpose: For men receiving androgen-suppression therapy (AST) for a rising postoperative or postradiation prostate-specific antigen (PSA), we evaluated whether a PSA nadir of more than 0.2 ng/mL was significantly associated with prostate cancer-specific mortality (PCSM).

Patients And Methods: The study cohort comprised 747 men with rising PSA and negative bone scan after surgery (n = 486) or radiation therapy (n = 261) who were treated with AST.

View Article and Find Full Text PDF

Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure.

J Clin Oncol

August 2005

Brigham and Women's Hospital, Department of Radiation Oncology, Dana-Faber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

Purpose: We evaluated whether men at risk for significant versus clinically insignificant prostate-specific antigen (PSA) failure after radical prostatectomy could be identified using information available at diagnosis.

Patients And Methods: A prospective prostate cancer screening study that enrolled, diagnosed, and treated 1,011 men with radical prostatectomy at Barnes-Jewish Hospital (St Louis, MO) from January 1, 1989, to June 1, 2002, for localized prostate cancer formed the study cohort. Preoperative predictors of a postoperative PSA doubling time (DT) of less than 3 months and more than 12 months or no PSA failure were identified using logistic regression.

View Article and Find Full Text PDF

Response to docetaxel/carboplatin in patients with hormone-refractory prostate cancer not responding to taxane-based chemotherapy.

Clin Prostate Cancer

June 2005

Department of Medical Oncology, Lake Center for Genitourinary Oncology, Dana-Faber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

Few treatment options are available for patients with metastatic hormone-refractory prostate cancer (HRPC) that is not responsive to or continues to progress after taxane-based chemotherapy. Although single-agent carboplatin has modest activity in HRPC, carboplatin chemotherapy could induce a synergistic effect when combined with taxanes in patients with disease resistant to taxane-based chemotherapy. We report a case series of 4 consecutive patients treated with docetaxel (60-70 mg/m2) plus carboplatin (area under the curve of 4/5) following progression after taxane-based chemotherapy.

View Article and Find Full Text PDF

Early detection of disease and scheduling of screening examinations.

Stat Methods Med Res

December 2004

Dana-Faber Cancer Institute, Department of Biostatistics and Computational Biology, 44 Binney Street, Boston, MA 02115, USA.

Special examinations exist for many chronic diseases, which can diagnose the disease while it is asymptomatic, with no signs or symptoms. The earlier detection of disease may lead to more cures or longer survival. This possibility has led to public health programs which recommend populations to have periodic screening examinations for detecting specific chronic diseases, for example, cancer, diabetes, cardiovascular disease and so on.

View Article and Find Full Text PDF

Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression.

Am J Pathol

April 2004

Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, and the Dana Faber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Activin A, a dimeric glycoprotein that belongs to the transforming growth factor-beta superfamily, governs cellular differentiation in a wide variety of models and has been implicated in the regulation of angiogenesis. We examined the role of activin A and its downstream signaling pathway in a murine model of inflammatory corneal neovascularization induced by mechanical injury (debridement), and in vitro in corneal epithelial cells. Activin A expression increased steadily from day 2 until day 8 after mechanical debridement in vivo, paralleling vascular endothelial growth factor (VEGF) expression.

View Article and Find Full Text PDF

Stem cell transplantation-harnessing of graft-versus-malignancy.

Curr Opin Hematol

November 2003

Stem Cell Transplantation Program, Dana-Faber Cancer Institute, Division of Medical Oncology and Hematology, Brigham, MA, USA.

Purpose Of Review: Allogeneic transplantation can cure a number of hematologic malignancies; however, the cost in morbidity and mortality is high. Much of the toxicity is a direct consequence of the intensity of the conditioning regimen. It has gradually been recognized that the conditioning regimen is important but not critical for the success of transplantation, particularly in the less aggressive hematologic malignancies.

View Article and Find Full Text PDF

Glycolysis and apoptosis are considered major but independent pathways that are critical for cell survival. The activity of BAD, a pro-apoptotic BCL-2 family member, is regulated by phosphorylation in response to growth/survival factors. Here we undertook a proteomic analysis to assess whether BAD might also participate in mitochondrial physiology.

View Article and Find Full Text PDF

Molecular regulation of vertebrate early endoderm development.

Dev Biol

September 2002

Department of Adult Oncology and Cancer Biology, Dana-Faber Cancer Institute, Boston, MA 02115, USA.

Detailed study of the ectoderm and mesoderm has led to increasingly refined understanding of molecular mechanisms that operate early in development to generate cellular diversity. More recently, a number of powerful studies have begun to characterize the molecular determinants of the endoderm, a germ layer previously neglected in developmental biology. Work in diverse model systems has converged on an integrated transcriptional and signaling pathway that serves to establish the vertebrate endoderm.

View Article and Find Full Text PDF

The two major hereditary breast cancer susceptibility genes, BRCA1 and BRCA2, are associated with early-onset breast and/or ovarian cancer and encode products that each interact with the product of the eukaryotic RecA homologue, hRad51. We have recently found that BRCA1 and BRCA2 coexist in a common biochemical complex. The two proteins also colocalize in subnuclear foci in somatic cells as well as on the axial elements of developing synaptonemal complexes in meiotic cells.

View Article and Find Full Text PDF

Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase.

J Biol Chem

October 1998

Department of Cancer Immunology & AIDS, Dana-Faber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Hydrogen peroxide-inducible clone (Hic)-5 is induced during the senescent process in human fibroblasts, and the overexpression of Hic-5 induces a senescence-like phenotype. Structurally, Hic-5 and paxillin, a 68-kDa cytoskeletal protein, share homology such as the LD motifs in the N-terminal half and the LIM domains in the C-terminal half. Here we show that Hic-5 binds to focal adhesion kinase (FAK) by its N-terminal domain, and is localized to focal adhesions by its C-terminal LIM domains.

View Article and Find Full Text PDF

Among the five immediate-early regulatory proteins of herpes simplex virus (HSV) type 1, only ICP0 is capable of activating all kinetic classes of viral genes. Consistent with its broad transactivating activity, ICP0 plays a major role in enhancing the reactivation of HSV from latency both in vivo and in vitro. Although not essential for viral replication, ICP0 confers a significant growth advantage on the virus, especially at low multiplicities of infection.

View Article and Find Full Text PDF
Article Synopsis
  • Antifolates like PT523 enhance DNA damage caused by topoisomerase inhibitors such as etoposide, leading to increased cytotoxicity in human squamous carcinoma cells.
  • Isobologram analysis revealed that combinations of PT523 or methotrexate with etoposide or novobiocin showed significant synergistic effects on cell death, demonstrating greater than additive effects.
  • In animal studies, PT523 with etoposide or novobiocin resulted in longer tumor growth delays compared to methotrexate combinations, indicating a more effective therapeutic strategy against cancer.
View Article and Find Full Text PDF
Article Synopsis
  • The study focused on identifying antigen presenting cells (APC) in lymphoid organs that can present external antigens using MHC class I molecules.
  • Five cell lines were created from murine bone marrow macrophages, showing they could efficiently present exogenous ovalbumin when attached to a phagocytic substrate, but not as efficiently when the antigen was soluble.
  • The findings revealed that the ability to present external antigens with MHC class I and class II is independently regulated, with some cell lines needing stimulation to present with MHC class II, highlighting the complexity of antigen presentation mechanisms.
View Article and Find Full Text PDF

Steel factor (SF) synergizes with a variety of hemopoietins to support the growth and differentiation of human progenitor cells. The human factor-dependent cell line MO7 has been used as a model to study the interaction of SF with other growth factors such as GM-CSF, because both factors support the proliferation of this cell line and are synergistic in combination. Previous studies have shown that this effect is not readily explained by the synergistic activation of early, cytosolic signal transduction intermediates such as tyrosine kinases, Raf-1, MAP2 kinase, or phospholipase C gamma.

View Article and Find Full Text PDF

We demonstrated earlier that individuals homozygous for conserved major histocompatibility complex (MHC)-extended haplotypes have low natural killer (NK) activity as measured by cytolysis of the K562 tumor cell lines. In the present study, we investigated the segregation and MHC linkage of NK activity in families in which MHC haplotypes of human histocompatibility leukocyte antigens (HLA)-A, -C, and -B, complotype, and DR specificities are known. In two informative families, low activity was inherited as a recessive trait linked to the MHC.

View Article and Find Full Text PDF

Dysregulation of hematopoietic cellular differentiation contributes to leukemogenesis. Unfortunately, relatively little is known about how cell differentiation is regulated. Considering that heat shock proteins (hsp) and specifically the small hsps have been increasingly linked to growth regulation, we sought to determine whether the mammalian small hsp (hsp28) is a growth-regulatory candidate during hematopoietic cell differentiation.

View Article and Find Full Text PDF